A Novel Bromodomain Inhibitor Reverses HIV-1 Latency through Specific Binding with BRD4 to Promote Tat and P-TEFb Association.
Front Microbiol
; 8: 1035, 2017.
Article
en En
| MEDLINE
| ID: mdl-28638377
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Risk_factors_studies
Idioma:
En
Revista:
Front Microbiol
Año:
2017
Tipo del documento:
Article